text.skipToContent text.skipToNavigation

Sartorius Stedim Biotech Investor Relations

Half-Year 2018 Results

Dr. Joachim Kreuzburg, CEO, will discuss the results with analysts and investors at 3.30 p.m. CET.

To register for the teleconference, please use the following link: here

Alternatively, you can dial into the teleconference, without registering, at: +49 (0) 69 566 03 6000

The presentation will be accessible through our website that day, 3.15 p.m. at: here

First-Quarter 2018 Results

Facts & Figures

Download a brief overview of Sartorius Stedim Biotech and its current economic development.

Fact Sheet Q1 2018

Annual Report 2017

Sartorius Capital Markets Day 2018

Preliminary Full-year Results January to December 2017

Nine-month Results January to September 2017

Half-Year Report January to June 2017